What do Analysts Say about Alexion Pharmaceuticals, Inc.(NASDAQ:ALXN) : Amphenol Corporation(NYSE:APH)

0
3

Alexion Pharmaceuticals, Inc. (ALXN) will report its next earnings on May 06 BMO. The company reported the earnings of $3.22/Share in the last quarter where the estimated EPS by analysts was $2.71/share. The difference between the expected and actual EPS was $0.51/share, which represents an Earnings surprise of 18.8%.

Many analysts are providing their Estimated Earnings analysis for Alexion Pharmaceuticals, Inc. and for the current quarter 21 analysts have projected that the stock could give an Average Earnings estimate of $2.58/share. These analysts have also projected a Low Estimate of $2.33/share and a High Estimate of $3.02/share.

In case of Revenue Estimates, 20 analysts have provided their consensus Average Revenue Estimates for Alexion Pharmaceuticals, Inc. as 1.29 Billion. According to these analysts, the Low Revenue Estimate for Alexion Pharmaceuticals, Inc. is 1.21 Billion and the High Revenue Estimate is 1.43 Billion. The company had Year Ago Sales of 1.2 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for ALXN to be -4.6%. They are projecting Next Quarter growth of -10.39%. For the next 5 years, Alexion Pharmaceuticals, Inc. is expecting Growth of 7.66% per annum, whereas in the past 5 years the growth was 2.37% per annum.

Some buy side analysts are also providing their Analysis on Alexion Pharmaceuticals, Inc., where 1 analysts have rated the stock as Strong buy, 1 analysts have given a Buy signal, 2 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.82 and Average Volume (3 months) is 2.7 million. The company’s P/E (price to earnings) ratio is 11.21 and Forward P/E ratio of 10.17.

The company shows its Return on Assets (ROA) value of 14.6%. The Return on Equity (ROE) value stands at 21.8%. While it’s Return on Investment (ROI) value is 16.9%.

While looking at the Stock’s Performance, Alexion Pharmaceuticals, Inc. currently shows a Weekly Performance of 17.16%, where Monthly Performance is 10.65%, Quarterly performance is 23.67%, 6 Months performance is 3.72% and yearly performance percentage is 4.61%. Year to Date performance value (YTD perf) value is 9.96%. The Stock currently has a Weekly Volatility of 4.29% and Monthly Volatility of 3.48%.

Amphenol Corporation (APH) will report its next earnings on Apr 22 BMO. The company reported the earnings of $0.71/Share in the last quarter where the estimated EPS by analysts was $0.73/share. The difference between the expected and actual EPS was $-0.02/share, which represents an Earnings surprise of -2.7%.

Many analysts are providing their Estimated Earnings analysis for Amphenol Corporation and for the current quarter 15 analysts have projected that the stock could give an Average Earnings estimate of $0.62/share. These analysts have also projected a Low Estimate of $0.55/share and a High Estimate of $0.69/share.

In case of Revenue Estimates, 13 analysts have provided their consensus Average Revenue Estimates for Amphenol Corporation as 1.75 Billion. According to these analysts, the Low Revenue Estimate for Amphenol Corporation is 1.62 Billion and the High Revenue Estimate is 1.85 Billion. The company had Year Ago Sales of 2.02 Billion.

These analysts also forecasted Growth Estimates for the Current Quarter for APH to be -30.4%. They are projecting Next Quarter growth of -21.05%. For the next 5 years, Amphenol Corporation is expecting Growth of 22.45% per annum, whereas in the past 5 years the growth was -20.05% per annum.

Some buy side analysts are also providing their Analysis on Amphenol Corporation, where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 3 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

The Relative Volume of the company is 0.63 and Average Volume (3 months) is 2.16 million. The company’s P/E (price to earnings) ratio is 26.6 and Forward P/E ratio of 26.6.

The company shows its Return on Assets (ROA) value of 10.2%. The Return on Equity (ROE) value stands at 26.2%. While it’s Return on Investment (ROI) value is 15.6%.

While looking at the Stock’s Performance, Amphenol Corporation currently shows a Weekly Performance of 7.63%, where Monthly Performance is 10.73%, Quarterly performance is 2.95%, 6 Months performance is -5.82% and yearly performance percentage is 12.33%. Year to Date performance value (YTD perf) value is -9.7%. The Stock currently has a Weekly Volatility of 2.13% and Monthly Volatility of 2.56%.

SHARE